Gracell Bio gracellbio.com


Public lists: Pharma Startups (6570)

Gracell Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease.

Gracell Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease.

Company (Alive / Active)

All investors data 15 Investors

Phone: +86-21-64031375

Fax:

12th Floor, 926 Yishan Road
Xu Hui District
 Shanghai,
Shanghai, China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Gracell Bio $185M Oct 20, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Gracell Bio Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Engineered immune cell capable of inducing secretion of anti-cd47 antibody Sep 27, 2018 Application